| Literature DB >> 33727687 |
Ken Karipidis1, Rohan Mate2, David Urban2, Rick Tinker2, Andrew Wood3.
Abstract
The increased use of radiofrequency (RF) fields above 6 GHz, particularly for the 5 G mobile phone network, has given rise to public concern about any possible adverse effects to human health. Public exposure to RF fields from 5 G and other sources is below the human exposure limits specified by the International Commission on Non-Ionizing Radiation Protection (ICNIRP). This state-of-the science review examined the research into the biological and health effects of RF fields above 6 GHz at exposure levels below the ICNIRP occupational limits. The review included 107 experimental studies that investigated various bioeffects including genotoxicity, cell proliferation, gene expression, cell signalling, membrane function and other effects. Reported bioeffects were generally not independently replicated and the majority of the studies employed low quality methods of exposure assessment and control. Effects due to heating from high RF energy deposition cannot be excluded from many of the results. The review also included 31 epidemiological studies that investigated exposure to radar, which uses RF fields above 6 GHz similar to 5 G. The epidemiological studies showed little evidence of health effects including cancer at different sites, effects on reproduction and other diseases. This review showed no confirmed evidence that low-level RF fields above 6 GHz such as those used by the 5 G network are hazardous to human health. Future experimental studies should improve the experimental design with particular attention to dosimetry and temperature control. Future epidemiological studies should continue to monitor long-term health effects in the population related to wireless telecommunications.Entities:
Keywords: Disease; Epidemiology; Health studies; Radiation
Year: 2021 PMID: 33727687 PMCID: PMC8263336 DOI: 10.1038/s41370-021-00297-6
Source DB: PubMed Journal: J Expo Sci Environ Epidemiol ISSN: 1559-0631 Impact factor: 5.563
Experimental studies investigating low-level RF fields above 6 GHz and genotoxicity.
| Reference | Biological system | Frequency range | Intensity | Exposure duration | Results | Quality |
|---|---|---|---|---|---|---|
| [ | Bacteria & Yeast | 9 GHz | 0.5 to 16 W/kg | 20 min | No change in ROS production at low exposure levels. SAR above the limit | No blinding |
| [ | Cells in culture | 100–150 GHz | 4 W/m2 | Up to 24 h | No DNA damage but an increased occurrence of micro-nucleation. SAR above limit | Inadequate dosimetry and no blinding |
| [ | Cells in culture | 25 GHz | 8 W/m2 | Up to 24 h | No DNA damage but an increased occurrence of micro-nucleation. SAR above limit | No blinding |
| [ | Cells in culture | 42 GHz | 1 W/m² | 20 min | MMW pre-exposure reduced DNA damage after x-ray exposure to leucocytes | Poor temperature control |
| [ | Cells in culture | 42 GHz | 1 W/m² | 20 min | MMW pre-exposure reduced DNA damage after x-ray exposure to leucocytes | Poor temperature control |
| [ | Cells in culture | 7 GHz | 5–300 W/m² | 10–60 min | No statistically significant increase in chromosome aberrations | Inadequate dosimetry and no blinding |
| [ | Cells in culture | 7 GHz | 5–300 W/m² | 10–60 min | No statistically significant increase in chromosome aberrations | Inadequate dosimetry and no blinding |
| [ | Cells in culture | 106 GHz | 0.43–43 W/m² | 5 h | Increase in spindle disturbances, but no indication of structural chromosome aberrations | Well designed |
| [ | Cells in culture | 106 GHz | 0.4–20 W/m² | 2–24 h | No DNA strand breaks or chromosome damage. SAR above limit | Inadequate temperature and sham control |
| [ | Miscellaneous | 65 GHz | 0.5 W/m² | Up to 120 min | Changes in DNA strand separation during artificial synthesis | Poor dosimetry and temperature control |
| [ | In vivo | 50 GHz | 0.0086 W/m2 | 2 h/day for 45 days | Increase in DNA double-strand breaks and a decrease in the levels of Protein kinase C | Low animal numbers (6 exposed) |
| [ | Cells in culture | 100 GHz | 0.31 W/m² | 1–24 h | Chromosomal changes and asynchronous centromeres replications. SAR above limit | No blinding |
| [ | Cells in culture | 60 GHz | 10 W/m² | 24 h | No increase in DNA strand breaks or heat shock protein expression | Well designed |
| [ | Cells in culture | 45 GHz | 10 W/m² | 24 h | No increase in mironucleation, DNA strand breaks or heat shock protein expression | No blinding |
| [ | In vivo | 10 and 50 GHz | 2.1 W/m2 | 2 h/day for 45 days | Increase in ROS and increases and decreases in enzymes that control the build-up of ROS | Low animal numbers (6 exposed) and no blinding |
| [ | Bacteria & Yeast | 69–71 GHz | Up to 5 W/m² | 30 min | Increase in indicators of DNA damage. SAR above limit | Inadequate dosimetry and temperature control |
| [ | In vivo | 16.5 GHz | 10 W/m2 | 2 h/day for 35 days | Increase in indicators of DNA damage. SAR above limit | Low animal numbers (6 exposed) and no blinding |
| [ | Cells in culture | 42 GHz | 2 W/m² | 1–60 s | Decreased nuclei electrical charge and increased chromatin condensation in the nuclei | No blinding, sham control not described |
| [ | Cells in culture | 35 GHz | 0.3 W/m2 | 10 s | Increase in chromatin condensation as indicated by an increase in heterochromatin granule quantity | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 36 GHz | 0.01–1 W/m2 | 1–10 s | Increase in chromatin condensation as indicated by an increase in heterochromatin granule quantity. SAR above limit | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 45–46 GHz | 0.1–10 W/m2 | 0.5–2 h | Increase in indicator of DNA damage | Statistical methods and dosimetry were not described |
| [ | Cells in culture | 120–130 GHz | 0.5–2.3 W/m² | 20 min | No indication of DNA damage or changes in cell cycle kinetics. SAR above limit | Inadequate temperature control |
Experimental studies investigating low-level RF fields above 6 GHz and other effects.
| Reference | Biological system | Frequency range | Intensity | Exposure duration | Results | Quality |
|---|---|---|---|---|---|---|
| [ | In vivo | 60 GHz | 5.1 W/m2 | 30 min/day to death | Increased survival for the leukaemia inoculated mice | No temperature control and sham controls |
| [ | Cells in culture | 41 to 42 GHz | 0.24–0.5 W/m² | 20 min | Frequency dependant change in ROS production | Inadequate dosimetry and temperature control methods not described |
| [ | Cells in culture | 41 to 42 GHz | 0.24–2.4 W/m² | 20 min | Frequency dependant change in ROS production | Inadequate dosimetry and poor temperature control |
| [ | Cells in culture | 42 GHz | 1 W/m² | 20 min | Changes in fatty acid concentrations in thymus cells and blood plasma | Poor temperature control and no blinding |
| [ | Cells in culture | 40 GHz | 1 W/m² | 20 min | Changes in fatty acid concentrations of tumour bearing mice and restoration of fatty acid levels in the thymus | Poor temperature control and no blinding |
| [ | Cells in culture | 40 GHz | 1 W/m² | 20 min | Accelerated recovery of fatty acid after X-ray exposure | Poor temperature control and no blinding |
| [ | Miscellaneous | 100 GHz | 0.31 W/m² | 1, 2 and 24 h | Reduction in enzyme activity and decreased stability of antigen antibody complexes | No blinding |
| [ | In vivo | 10 and 50 GHz | 0.0086 W/m2 | 2 h/day for 45 days | Increase and decrease in enzymes that control the build-up of ROS. Changes in cell cycle kinetics | Low animal numbers (6 exposed) |
| [ | Miscellaneous | 53–78 GHz | 0.1 – 10000 W/m2 | Up to 40 min | Temperature oscillations in the liquid medium. SAR above limit | Inadequate dosimetry, no sham control and no blinding |
| [ | In vivo | 10 GHz | 2.1 W/m2 | 2 h/day for 45 days | Decrease in the activity of histone kinase and an increase in ROS and the rate of apoptosis. There was also changes in cell cycle kinetics | Low animal numbers (6 exposed), no blinding |
| [ | In vivo | 9.4 GHz | 10–100 W/m² | 1 h/day for 2 weeks | Increase in occurrence of translocations and unpaired chromosomes during meiosis in sperm cells of mice | Inadequate dosimetry and temperature control |
| [ | Human volunteers | 77 GHz | 0.03 W/m² | 15 min | No alterations of autonomic nerve activity or cardiovascular function | Inadequate dosimetry and temperature control |
| [ | In vivo | 53 GHz | 10–100 W/ m2 | 20 min/day for 30 days | No effects below limit, above the limit the effect of hydrocortisone on gamma-glutamyl transpeptidase was blocked | No description of dosimetry and poor temperature control |
| [ | In vivo | 34 GHz | 0.2 W/m² | 17 h/day for 10 days | Increase in progenitors of granulocytes and macrophages in the bone marrow of exposed mice | Poor temperature control and statistical analysis not described |
| [ | Cells in culture | 42 GHz | 0.195 W/m² | 20 min | Enhanced response of primed neutrophils to a chemotactic peptide | No blinding and poor temperature control |
| [ | Miscellaneous | 1–10 GHz | 0.05–0.5 W/ m2 | Up to 10 h | Exposure decreased the motility of the protozoa S. ambiguum and their non-exposed offspring | Inadequate dosimetry and no blinding |
| [ | In vivo | NS | 3 W/m² | 3.5–32 h for 63 days | Increase in the occurrence of abnormal sperm and an increase in litter size of exposed male mice | No description of dosimetry or temperature control |
| [ | Cells in culture | 41–74 GHz | Up to 10000 W/m2 | 1 h | No effect on the ultracellular structure of the cells when temperature was controlled | Inadequate dosimetry, statistical analysis not described |
| [ | Cells in culture | 42 GHz | 0.3 W/m² | 5–15 min | No change to sperm membrane integrity or nuclear chromatin status. Increase in percentage of mobile sperm | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 66–76 GHz | 2 × 10−5 – 0.000103 W | NS | Frequency specific differences in the attenuation of MMW in healthy and tumour cells | Inadequate dosimetry, no sham or temperature control |
NS Not stated in the study.
Epidemiological studies investigating occupational exposure to radar at frequencies above 6 GHz.
| Reference | Type of study | Study population | Exposure assessment | Disease | Risk Estimate | Limitations |
|---|---|---|---|---|---|---|
| [ | Cross-sectional | Norwegian Navy personnel (10,497 men) | Self-reported | Infertility | OR 1.86 (1.46–2.37) | No information on confounding factors including sailing time |
| [ | Cohort (retrospective) | Norwegian Navy personnel followed from 1967 to 2008 (28,337 men) | Job-exposure matrix | Perinatal mortality | Acute exposure OR 2.87 (1.25–6.59); Long-term exposure OR 0.97 (0.69–1.37) | No information on confounding factors; Prone to multiple testing |
| [ | Case-control | General population of five German cities (269 cases and 797 controls) | Self-reported and expert assessment | Testicular cancer | OR 1.0 (0.60–1.75) | Only 57% of identified controls participated |
| [ | Case-control | U.S. military veterans (621 cases and 958 controls) | Self-reported | Amyotrophic lateral sclerosis | OR 1.74 (0.89–3.38) | Likely under-ascertainment of non-exposed cases; Prone to multiple testing |
| [ | Cohort (retrospective) | French Navy personnel followed from 1975 to 2000 (39,850 men) | Expert assessment | All-cause mortality All-cancer mortality | RR 1.0 (0.88–1.14) RR 0.92 (0.69–1.24) | 43 % missing causes of death; No information on relevant confounding factors |
| [ | Cohort (retrospective) | Officers from two police departments in Washington, US, followed from 1979 to 1991 (340 men) | Job title | Testicular cancer | O/E 6.9 ( | Exposure was only assessed for the 6 cases in the cohort; No information on confounding factors |
| [ | Case-control | General US and Canadian population (538 cases and 504 controls, children) | Expert assessment | Neuroblastoma in offspring | OR 2.2 (0.6–8.3) | Result based on only 9 cases and 3 controls exposed to radar |
| [ | Cohort (retrospective) | Belgian military personnel followed from 1968 to 2003 (27,671 men) | Job title | All-cause mortality | SMR 1.05 (0.95–1.16) | Not all causes of death ascertained (76% in the radar group and 72% in the control group); No information on relevant confounding factors |
| [ | Cohort (retrospective) | Belgian professional military personnel followed from 1968–2004 (7,349 men) | Job title | All-cause mortality All-cancer mortality | RR 1.04 (0.96–1.14) RR 1.23 (1.03–1.47) | Not all causes of death ascertained (71% in the radar group and 70% in the control group); No information on relevant confounding factors |
| [ | Case-control | General population of Languedoc-Roussillon, France (445 cases and 1025 controls) | Job title | Non-Hodgkin’s lymphoma | OR 1.3 (0.5–3.3) | Low participation among the controls (52.2%); Low number of cases (7) and controls (14) exposed to radar |
| [ | Cohort (retrospective) | Officers from police departments in Ontario, Canada, followed from 1964 to 1995 (22,197 men) | Job title | All-cancer Melanoma | SIR 0.9 (0.83–0.98) SIR 1.45 (1.10–1.88) | No information on confounding factors; Significant loss to follow up (22%) |
| [ | Case-control (nested) | US Air Force service personnel (230 cases and 920 controls, men) | Job-exposure matrix | Brain cancer | OR 1.39 (1.01–1.9) | Lack of diagnosis confirmation; No potential confounders were included in the analysis |
| [ | Cohort (retrospective) | US Navy personnel followed from 1950 to 1997 (40,890 men) | Job title | All-cause mortality All-cancer mortality | RR 0.87 (0.83–0.9) RR 0.8 (0.74–0.87) | Under-ascertainment of cases; Limited exposure assessment period; No information on possible confounders |
| [ | Case-control | General Swedish population (148 cases and 314 controls, men) | Job title | Testicular cancer | OR 2.0 (0.3–14.2) | Result based on only 2 radar workers and 3 controls |
| [ | Case-control | Patients from medical institutions in Washington, US (271 cases and 259 controls, men) | Self-reported | Testicular cancer | OR 1.1 (0.7–1.9) | Short exposure period; No response rates reported |
| [ | Case-control | Patients from the Ocular Oncology Unit at the University of California, US (221 cases of 447 controls, men) | Self-reported | Uveal melanoma | OR 2.1 (1.1–4.0) | Prone to multiple testing |
| [ | Case-control | General population Milan, Italy (263 cases and 287 controls) | Self-reported | Bladder Cancer | No association, risk estimate not reported | Prone to multiple testing; Small number of cases across all the agents investigated |
| [ | Cross-sectional | Norwegian Navy personnel (3,100 births from 1,438 parents) | Self-reported | Congenital anomalies | OR 4.0 (1.9–8.6) | The response rate was only 58%; Prone to multiple testing |
| [ | Cross-sectional | Norwegian Navy personnel (3,752 men) | Expert assessment | Infertility | OR 2.28 (1.27–4.09) | No adjustment made for time spent on a boat |
| [ | Cohort study (retrospective) | US Navy enlisted personnel followed from 1950 to 1974 (40,890 men) | Job title | All-cause mortality All-cancer mortality | MR 0.96 MR 1.04 | Under-ascertainment of cases; Limited exposure assessment period; No information on possible confounding factors |
| [ | Case-control | Brazilian Navy personnel (40 cases and 671 controls, men) | Job title | Brain cancer | OR 0.56 (0.17–1.82) | Small number of cases (40); Lack of diagnosis confirmation; Use of last job title only |
| [ | Case-control | General population of Essen, Germany (118 cases and 475 controls) | Self-reported | Uveal Melanoma | OR 0.4 (0.0–2.6) | High non-response among the population controls (52%) |
| [ | Meta-analysis | Populations from Groves et al. (2002), Degrave et al. (2009) and Dabouis et al. (2014) | Various | All-cancer mortality | MR 0.81 (0.78–0.83) | Only six studies included in the meta-analysis with significant heterogeneity between studies |
| [ | Case-control | Military personnel from Brest, France (60 cases and 165 controls, couples) | Self-reported | Infertility | OR 0.8 (0.4–1.6) | No comparison in sperm characteristics between cases and controls |
| [ | Case-control | Patients from 5 cities in France (229 cases and 800 controls, men) | Job title | Testicular cancer | OR 0.84 (0.38–1.87) | Low participation (39%) in control group |
OR Odds ratio, RR Relative risk, O/E Observed to expected ratio, SIR Standardised incidence ratio, MR Mortality ratio
Experimental studies investigating low-level RF fields above 6 GHz and cell proliferation.
| Reference | Biological system | Frequency range | Intensity | Exposure duration | Results | Quality |
|---|---|---|---|---|---|---|
| [ | Cells in culture | 40–90 GHz | 0.5–1000 W/m2 | 8 min | No change in cell survival at exposure levels below the limits | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 53–78 GHz | 1 µW, 44–46 mW | 1–3 h/day for 5–10 days | Reduced cancer cell proliferation and changes in cell morphology | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 53–78 GHz | 0.0007 W/m2 | 1–3 h/day for 5–10 days | Reduced cancer cell proliferation and changes in cell morphology | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 53–78 GHz | 0.01 W/m2 | 1 h/day for 4 days | Reduction in viable cancer cells and changes in cell structural morphology | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 42–54 GHz | 1.1–3.7 W/m2 | 1 h/day for 4 days | No evidence of anti-proliferation effects in exposed cancer cells | Inadequate dosimetry and poor temperature control |
| [ | Cells in culture | 53–78 GHz | 7×10–4 W/m2 | 1 h/day for 12 days | Unclear results due to the in text results not matching supporting conclusions | Poor temperature control and no blinding |
| [ | Bacteria & Yeast | 99 GHz | 2 W/m2 | 1–19 h | No statistically significant changes in cell proliferation or survival. SAR above limit | No blinding |
| [ | Bacteria & Yeast | 42 GHz | Up to 0.08 W | Up to 4 h | No change in cell proliferation or viability | No blinding |
| [ | Bacteria & yeast | 40–43 GHz | 0.005–0.5 W/m2 | 2 and 5.5 h | No changes in cell proliferation | Inadequate sham control and no blinding |
| [ | Bacteria & Yeast | 42 GHz | 40 mW | NS | Enhanced and inhibited rates of cell proliferation | Inadequate dosimetry, statistical analysis not described |
| [ | Bacteria & Yeast | 42 GHz | 1–20 W/m² | Up to 12 h | Enhanced and inhibited rates of cell proliferation | Inadequate sham control and no blinding |
| [ | Bacteria & Yeast | 51–53 GHz | 0.6 W/m2 | Up to 2 h | Increase in cell diameter and inhibition of cell growth | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 61–62 GHz | 1.3 W/m2 | 30 min | MMW pre-exposure did not change cell survival or alter the frequency of mutations. SAR above limit | Inadequate temperature control |
| [ | Bacteria & Yeast | 61 GHz | 10 W/m² | Up to 1 h | Increase in cell survival if MMW exposure occurred after UVC exposure. No effect of MMW exposure alone. SAR above limit | No blinding |
| [ | Neural activity | 60 GHz | 10 W/m² | 24 h | No change in neurite outgrowth | No blinding |
| [ | Bacteria & Yeast | 51–53 GHz | 0.6 W/m² | 1 h | Changes in ion transport across the membrane and an inhibitory effect on bacteria proliferation and survival | Inadequate dosimetry and no blinding |
| [ | Bacteria & Yeast | 51–53 GHz | 0.6 W/m2 | Up to 1 h | Changes in ion transport across the membrane and an inhibitory effect on bacteria proliferation | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 70–73 GHz | 0.6 W/m2 | Up to 1 h | Inhibition of proliferation and changes in membrane proteins | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 70–73 GHz | 0.6 W/m2 | Up to 2 h | Effect on bacterial growth and surrounding water medium | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 51–73 GHz | 0.6 W/m2 | 1 h | Enhanced inhibitory effect of antibiotics on bacterial proliferation. Changes in ion transport | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 51–53 GHz | 0.6 W/m2 | 1 h | Changes in the bacterial proliferation and survival. Changes in ion transport | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 65–75 GHz | NS | NS | Inhibition and stimulation of bacterial growth at specific frequencies | No details on dosimetry and no blinding |
| [ | Bacteria & Yeast | 136 GHz | 7×10–6 W | Up to 4 h | Inhibition and stimulation of bacterial growth at specific frequencies | No details on dosimetry and no blinding |
| [ | Cells in culture | 70–300 GHz | Up to 0.0127 W/m² | 3–94 h | No change in proliferation, cell activity or cytotoxicity | No blinding |
NS Not stated in the study.
Experimental studies investigating low-level RF fields above 6 GHz and gene expression.
| Reference | Biological system | Frequency range | Intensity | Exposure duration | Results | Quality |
|---|---|---|---|---|---|---|
| [ | Bacteria & Yeast | 41–52 GHz | 0.01–1 W/m² | 5–10 min | Frequency dependant changes in DNA conformation based on AVTD method and changes in DNA repair | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 52 GHz | 1 W/m² | 5–10 min | Frequency dependant changes in DNA conformation based on AVTD method and changes in DNA repair | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 41–52 GHz | 0.01–3 W/m2 | 30 min | Frequency dependant changes in DNA conformation based on AVTD method and changes in DNA repair | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 41–52 GHz | 0.1–1 W/m2 | 5–10 min | Frequency dependant changes in DNA conformation based on AVTD method and changes in DNA repair | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 41–52 GHz | 1016–10−6 W/m2 | 10 min | Frequency dependant changes in DNA conformation based on AVTD method and changes in DNA repair | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 41–52 GHz | 0.1–1 W/m2 | 5 min | Frequency dependant changes in DNA conformation based on AVTD method and suppression of DNA repair | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 41 GHz | 10−7 – 1 W/m2 | 10 min | Frequency dependant changes in DNA conformation based on AVTD method. SAR above limit | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 41–52 GHz | 10-16 – 1 W/m2 | 10–50 min | Frequency dependant changes in DNA conformation based on AVTD method and changes in cell developmental dynamics | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 52 GHz | 10−19 – 0.003 W/m2 | 10 min | Frequency dependant changes in DNA conformation based on AVTD method | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 38–75 GHz | Up to 5840 W/m2 | 15 min | No changes in protein synthesis and no resonance effects detected even at high exposure levels | Temperature control and dosimetry methods were not described |
| [ | Bacteria & Yeast | 26.5–90.0 GHz | Up to 3000 W/m2 | Up to 5 s | No resonance effects detected even at exposure levels above the limits | Statistical methods not described |
| [ | Cells in culture | 60 GHz | 18 W/m2 | 1–24 h | Five genes were reported to have transient expression changes after exposure. SAR above limit | No blinding, poor temperature control |
| [ | Cells in culture | 60 GHz | 1.4 W/m² | 24–72 h | No change in ER homeostasis, protein folding, secretions or transcription factors | No blinding |
| [ | Cells in culture | 59–61 GHz | 0.9–1.4 W/m² | 24 h. | No changes in mRNA expression of chaperone proteins. SAR above limit | No blinding |
| [ | Bacteria & Yeast | 51 GHz | Up to 10–7 W/m2 | 10 min | Frequency dependant changes in DNA conformation. Cell to cell communication reported to enhance this effect | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 52 GHz | 10−14 – 10 W/m² | Up to 10 min | Frequency dependant changes in DNA conformation. Cell to cell communication reported to enhance this effect | Inadequate dosimetry and temperature control |
| [ | Cells in culture | 60 GHz | 2.7 W/m² | 1–33 h | No change in the expression of stress sensitive genes | Inadequate temperature control and no blinding |
| [ | Cells in culture | 60 GHz | 0.054–5.4 W/m² | 1–33 h | No change in expression of chaperone proteins, heat shock proteins or reporting genes | No blinding |
| [ | Cells in culture | 60 GHz | 10 W/m² | 24 h | No change in protein conformation, gene expression, cell viability or cell growth. SAR above limit | Temperature control not described and no blinding |
Experimental studies investigating low-level RF fields above 6 GHz and cell signalling and electrical activity.
| Reference | Biological system | Frequency range | Intensity | Exposure duration | Results | Quality |
|---|---|---|---|---|---|---|
| [ | Neural activity | 38–54 GHz | 4.8 W/m² | 20–60 min | Change in the duration of the inter-spike intervals | Inadequate dosimetry and temperature control |
| [ | Neural activity | 10 GHz | 2.5 W/m² | 4 min | Increase and decrease in the variance of inter-spike intervals. | No sham control and poor temperature control |
| [ | Neural activity | 10 GHz | 0.007–700 W/m² | 1 min | Decrease in the distribution of the inter-spike intervals with increasing exposure levels | No sham control and poor temperature control |
| [ | Neural activity | 40–52 GHz | 2.4–30 W/m² | 10 or 60 min | Reduction in the latency period and an increase in amplitude of CAPs | No blinding |
| [ | Neural activity | 40 GHz | 0.2–26 W/m² | 23 min | Reduction in the effect of high rate stimulus causing a decrease in the test CAP | No blinding |
| [ | Neural activity | 40–50 GHz | 2.5–25 W/m² | 12–50 min | Reduction in the effect of high rate stimulus causing a decrease in the test CAP | No blinding |
| [ | Neural activity | 60 GHz | 0.00071–6 W/m² | NS | Reduced neuron firing rate and a decrease in input resistance | No blinding |
| [ | Neural activity | 60 GHz | Up to 0.008 W/m² | 1 min | Reduced neuron firing rate and a decrease in input resistance | No blinding |
| [ | Neural activity | 17–60 GHz | 9–140 W/m² | 60 s | Reduction in the action potential firing rate | No blinding |
| [ | Neural activity | 60 GHz | 10–40 W/m² | 60 s | Reduction in the action potential firing rate | No blinding |
NS Not stated in the study.
Experimental studies investigating low-level RF fields above 6 GHz and membrane effects.
| Reference | Biological system | Frequency range | Intensity | Exposure duration | Results | Quality |
|---|---|---|---|---|---|---|
| [ | Artificial cell suspensions | 53–78 GHz | Up to 0.0027 W/kg | 4 h | Delays in the transition from gel to liquid phase or vice versa | Statistical methods were not described and no blinding |
| [ | Artificial cell suspensions | 53–78 GHz | Up to 0.1 W/ m2 | 4 h | Reduction in water quadrupole splitting on simulated membrane | Statistical methods were not described and no blinding |
| [ | Artificial cell suspensions | 53–78 GHz | < 0.03 W/m2 | Up to 40 h | Delays in the transition from gel to liquid phase or vice versa | Statistical methods were not described and no blinding |
| [ | Miscellaneous | 30 GHz | 10–35 W/m2 | 1 h | Exposure increased membrane permeability | No sham control |
| [ | Artificial cell suspensions | 52–72 GHz | Up to 0.1 W/m2 | Up to 4 h | Change in size due to osmotic stress and a decrease in water permeability | Inadequate dosimetry and poor temperature control |
| [ | Artificial cell suspensions | 53 GHz | 1.1 W/kg | Up to 30 min | Enhanced efflux of potassium from vesicles with increased amplitude of the electrical signals | Statistical methods were not described and no blinding |
| [ | Miscellaneous | 90–160 GHz | 1.49 W/kg | Up to 10 min | Decrease in the cell volume of neurons and rat brain tissue | Inadequate dosimetry and temperature control |
| [ | Artificial cell suspensions | 53 GHz | Up to 1 W/m2 | Up to 2 min | Enhancement of the CA reaction rate resulting in membrane permeability changes | No blinding |
| [ | Cells in culture | 42 GHz | 1 W/m2 | Up to 30 min | Changes in binding affinity of channels for calcium with associated lowering of channel opening probability | No sham, dosimetry description or temperature control |
| [ | Bacteria & Yeast | 51–53 GHz | 0.6 W/m2 | Up to 2 h | Increase in cell diameter and inhibition of cell growth | Inadequate dosimetry and temperature control |
| [ | Artificial cell suspensions | 53 GHz | 1 W/m2 | Up to 10 min | Cell morphology changes i.e. elongation and diffusion of dye across the membrane | Statistical methods were not described and no blinding |
| [ | Cells in culture | 37 GHz | 2 W/m2 | 1–60 s | Increase in cell permeability and both increased and decrease cell electronegativity | No sham and temperature control |
| [ | Cells in culture | 35 GHz | 0.3 W/m2 | 10 s | Reported an indication of cell membrane damage | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 51–53 GHz | 0.6 W/m² | 1 h | Changes in ion transport across the membrane and inhibitory effect on bacteria proliferation and survival | Inadequate dosimetry and no blinding |
| [ | Bacteria & Yeast | 51–53 GHz | 0.6 W/m2 | Up to 1 h | Changes in ion transport across the membrane and inhibitory effect on bacteria proliferation | Inadequate dosimetry and poor temperature control |
| [ | Bacteria & Yeast | 70–73 GHz | 0.6 W/m2 | Up to 1 h | Inhibition of proliferation and changes in membrane proteins | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 70–73 GHz | 0.6 W/m2 | Up to 2 h | Effect on bacterial growth and changes in ion transport | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 51–73 GHz | 0.6 W/m2 | 1 h | Enhanced the inhibitory effect of antibiotics on bacterial proliferation. Changes in ion transport | Inadequate dosimetry and temperature control |
| [ | Bacteria & Yeast | 51–53 GHz | 0.6 W/m2 | 1 h | Changes in the bacterial proliferation and survival. Changes in ion transport | Inadequate dosimetry and temperature control |
| [ | Artificial cell suspensions | 60 GHz | Up to 9 W/m² | Up to 5 h | Increases in lateral membrane pressure but no changes to the microdomain organisation | Statistical analysis not described and no blinding |